AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsInformation ScienceHealth Care
Adaptive ImmunityImmunity, InnateImmunityImmunity, CellularImmunity, ActiveDendritic CellsMice, Inbred C57BLT-LymphocytesImmunity, MucosalMice, KnockoutToll-Like ReceptorsCytokinesMice, Inbred BALB CAdaptation, PhysiologicalImmunity, HumoralLymphocyte ActivationInterferon-gammaCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesKiller Cells, NaturalImmune SystemModels, ImmunologicalAdaptation, BiologicalSignal TransductionReceptors, Pattern RecognitionAntigen PresentationTh1 CellsAdjuvants, ImmunologicPlant ImmunitySpleenInflammationInterleukin-12Immunologic MemoryMacrophagesMyeloid Differentiation Factor 88Immune EvasionCells, CulturedFlow CytometryAntibody FormationDisease Models, AnimalB-LymphocytesImmunity, Maternally-AcquiredT-Lymphocyte SubsetsHost-Pathogen InteractionsImmune ToleranceVaccinesToll-Like Receptor 4VaccinationImmunomodulationVirus DiseasesMice, TransgenicToll-Like Receptor 2Immunoglobulin GTh2 CellsListeriosisInterleukin-17Genes, RAG-1Membrane GlycoproteinsCell DifferentiationAdoptive TransferMolecular Sequence DataAntibodies, ViralAntigens, CD11cCancer VaccinesAntigensAntigen-Presenting CellsEvolution, MolecularTh17 CellsT-Lymphocytes, RegulatoryGene Expression RegulationReceptors, AntigenInterferon Type IAllergy and ImmunologyAutoimmunityMice, Inbred C3HLungBiological EvolutionCytotoxicity, ImmunologicNatural Killer T-CellsImmunity, HerdT-Lymphocytes, CytotoxicImmunotherapyChemokinesAntigens, CDT-Lymphocytes, Helper-InducerPhagocytosisLipopolysaccharidesOvalbuminInterleukin-10Antibodies, BacterialCRISPR-Cas SystemsEnzyme-Linked Immunosorbent AssayInterleukinsVaccines, AttenuatedToll-Like Receptor 9LymphocytesLymphoid TissueEpitopes, T-LymphocyteHagfishesCell Line

Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. (33/1427)

 (+info)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. (34/1427)

 (+info)

The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy. (35/1427)

 (+info)

Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial. (36/1427)

 (+info)

Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants. (37/1427)

 (+info)

The DC-SIGN of zebrafish: insights into the existence of a CD209 homologue in a lower vertebrate and its involvement in adaptive immunity. (38/1427)

 (+info)

The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model. (39/1427)

 (+info)

Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV. (40/1427)

 (+info)